Withaferin A inhibits adipogenesis in 3T3-F442A cell line, improves insulin sensitivity and promotes weight loss in high fat diet-induced obese mice

The increased prevalence of obesity and associated insulin resistance calls for effective therapeutic treatment of metabolic diseases. The current PPARγ-targeting antidiabetic drugs have undesirable side effects. The present study investigated the anti-diabetic and anti-obesity effects of withaferin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Khalilpourfarshbafi, Manizheh, Devi Murugan, Dharmani, Abdul Sattar, Munavvar Zubaid, Sucedaram, Yamuna, Abdullah, Nor Azizan
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6588247/
https://ncbi.nlm.nih.gov/pubmed/31226166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0218792
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars